Tilray Inc (NASDAQ:TLRY – Get Free Report)’s stock price shot up 0.9% during mid-day trading on Thursday . The stock traded as high as $1.73 and last traded at $1.72. 4,041,480 shares traded hands during mid-day trading, a decline of 84% from the average session volume of 25,466,322 shares. The stock had previously closed at $1.70.
Tilray Price Performance
The company has a debt-to-equity ratio of 0.10, a current ratio of 2.27 and a quick ratio of 1.42. The firm has a 50-day moving average price of $1.82 and a 200-day moving average price of $1.88.
Tilray (NASDAQ:TLRY – Get Free Report) last posted its quarterly earnings data on Monday, July 29th. The company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). Tilray had a negative net margin of 30.26% and a negative return on equity of 2.63%. The company had revenue of $229.90 million for the quarter, compared to the consensus estimate of $226.20 million. During the same period last year, the business earned ($0.15) EPS. The firm’s quarterly revenue was up 24.8% on a year-over-year basis. Equities research analysts forecast that Tilray Inc will post -0.12 EPS for the current year.
Institutional Trading of Tilray
About Tilray
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Featured Stories
- Five stocks we like better than Tilray
- Conference Calls and Individual Investors
- Does A&F’s Q2 Earnings Win Point to a Strong Holiday Season?
- How to Use the MarketBeat Stock Screener
- Best Buy Stock Flashes Bullish Signal, Challenges Remain
- When to Sell a Stock for Profit or Loss
- Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest Results
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.